Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Study of Patients With Chronic Disease
Clinical trial update indicates the study NCT04263727 involving patients with chronic respiratory diseases has been terminated.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
A recruiting clinical trial investigates the relationship between Vitamin D and alveolar macrophages in Idiopathic Pulmonary Fibrosis (IPF).
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: P4O2 ILD Extension
A clinical trial update describes an extension of the P4O2 interstitial lung disease study led by Amsterdam UMC (VUmc) and currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF [Phase 2]
Phase 2 clinical trial update showing completion of a study evaluating the efficacy, safety, and tolerability of BBT-877 in patients with id…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Advancing Prevention of Pulmonary Fibrosis
This update covers an ongoing University of Colorado, Denver clinical trial focused on preventing pulmonary fibrosis, including idiopathic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: The Genetics of Pulmonary Fibrosis
A clinical trial update from the University of Colorado, Denver, investigating the genetics of Idiopathic Pulmonary Fibrosis, with the study…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 trial evaluating intravenous SHR-1906 for idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls [NA]
A completed clinical trial studying a single-cell atlas of airways in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosi…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions [Phase 1]
A completed Phase 1 pharmacokinetic study evaluating pirfenidone modified-release tablets in healthy volunteers under fasting and fed condit…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） [Phase 1, Phase 2]
Phase 1/2 trial evaluating tolerability, pharmacokinetics, and preliminary efficacy of ZSP1603 in idiopathic pulmonary fibrosis has complete…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
A completed prospective study investigating molecular diagnosis for idiopathic interstitial pneumonias.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
This update reports the completion of a clinical trial validating a risk stratification score for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating long-acting octreotide for idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 clinical trial update indicating completion of a study evaluating 18F-FMISO PET hypoxia imaging in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib [Phase 1]
A Phase 1 study assessing safety, tolerability, and blood levels of GSK3915393 in healthy participants of Chinese, Japanese, and European an…
-
FDA approval · 2025-02-04FDA Approved: PIRFENIDONE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for pirfenidone submitted by Accord Healthcare Inc., adding an approved pirfenidone product to the m…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT [EARLY_Phase 1]
An early-phase study update on detecting integrin αvβ6 with PET/CT in patients with idiopathic pulmonary fibrosis, primary sclerosing cholan…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects [Phase 1]
Vicore Pharma AB's first-in-human Phase 1 study of C106 in healthy subjects assessed safety, tolerability, and pharmacokinetics; results hav…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis [NA]
Clinical trial update for a study evaluating yoga's effect on quality of life in patients with idiopathic pulmonary fibrosis; the trial is c…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib [NA]
A clinical trial update indicates a study on high oxygen delivery to preserve exercise capacity in idiopathic pulmonary fibrosis patients tr…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Skeletal Muscle Function in Interstitial Lung Disease [NA]
This ClinicalTrials.gov entry updates an ongoing University of British Columbia study on skeletal muscle function in interstitial lung disea…
-
FDA approval · 2024-12-18FDA Approved: PIRFENIDONE CAPSULE, 267 MG — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original ANDA for pirfenidone capsule 267 mg by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial results report safety, pharmacokinetics, and pharmacodynamics of garadacimab in idiopathic pulmonary fibrosis. The study is co…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating jaktinib hydrochloride tablets in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Quality of Life in IPF - Patient and Physician Perceptions
A completed clinical trial evaluating quality of life in Idiopathic Pulmonary Fibrosis. The study assesses patient and physician perceptions…